Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
S. Y. Ran, Q. Yu, Y. Chen & S. Q. Lin. (2017) Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study. Climacteric 20:4, pages 391-396.
Read now
Read now
Nicoletta Biglia, Silvia Maffei, Stefano Lello & Rossella E. Nappi. (2010) Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Gynecological Endocrinology 26:11, pages 804-814.
Read now
Read now
John Studd. (2007) Variations on hormone replacement therapy: An answer to the ‘one dose fits all’ Women's Health Initiative study. Gynecological Endocrinology 23:11, pages 665-671.
Read now
Read now
Articles from other publishers (32)
Franklin José Espitia De La Hoz. (2022) Influencia de la tibolona en la función sexual y seguridad cardiovascular en la mujer posmenopáusica. Revista Ciencias Biomédicas 11:1, pages 66-79.
Crossref
Crossref
Stefano Lello, Giovanni Scambia & Anna Capozzi. (2022) Terapia ormonale sostitutiva e osteoporosi postmenopausale. L'Endocrinologo 23:1, pages 61-64.
Crossref
Crossref
Andrea R Genazzani, Patrizia Monteleone, Andrea Giannini & Tommaso Simoncini. (2021) Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice. Human Reproduction Update 27:6, pages 1115-1150.
Crossref
Crossref
Marilene Lopes Ângelo, Fernanda de Lima Moreira, Ana Laura Araújo Santos, Hérida Regina Nunes Salgado & Magali Benjamim de Araújo. (2021) A Review of Analytical Methods for the Determination of Tibolone: Pharmacokinetics and Pharmaceutical Formulations Analysis and Application in Doping Control. Current Pharmaceutical Analysis 17:1, pages 31-39.
Crossref
Crossref
Marta Caretto, Andrea Giannini, Tommaso Simoncini & Andrea R. Genazzani. 2020. Obesity and Gynecology. Obesity and Gynecology
273
279
.
Marta Caretto & Tommaso Simoncini. 2020. Female Reproductive Dysfunction. Female Reproductive Dysfunction
349
366
.
Marta Caretto & Tommaso Simoncini. 2020. Female Reproductive Dysfunction. Female Reproductive Dysfunction
1
18
.
L. Vignozzi, N. Malavolta, P. Villa, G. Mangili, S. Migliaccio & S. Lello. (2018) Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO. Journal of Endocrinological Investigation 42:5, pages 609-618.
Crossref
Crossref
Andrea Giannini, Maria Magdalena Montt-Guevara, Jorge Eduardo Shortrede, Giulia Palla, Peter Chedraui, Andrea Riccardo Genazzani & Tommaso Simoncini. 2019. Postmenopausal Diseases and Disorders. Postmenopausal Diseases and Disorders
225
236
.
Marta Caretto, Andrea Giannini, Tommaso Simoncini & Andrea R. Genazzani. 2018. Reproductive Medicine for Clinical Practice. Reproductive Medicine for Clinical Practice
177
189
.
Santiago Palacios & Mariella Lilue. 2017. Menopause. Menopause
197
212
.
Tommaso Simoncini, Silvia Pisaneschi, Stefania Spina, Guja Bernacchi, Silvia Di Bello, Elena Cecchi, Paolo Mannella & Andrea R. Genazzani. 2014. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
247
255
.
R. Rajamanohara, J. Robinson, J. Rymer, R. Patel, I. Fogelman & G. M. Blake. (2010) The effect of weight and weight change on the long-term precision of spine and hip DXA measurements. Osteoporosis International 22:5, pages 1503-1512.
Crossref
Crossref
Teun M. Post, Serge C.L.M. Cremers, Thomas Kerbusch & Meindert Danhof. (2010) Bone Physiology, Disease and Treatment. Clinical Pharmacokinetics 49:2, pages 89-118.
Crossref
Crossref
Jae-Suk Chang. (2010) Osteoporotic Fracture-Medical Treatment. Journal of the Korean Fracture Society 23:3, pages 326.
Crossref
Crossref
P. D. Delmas, S. R. Davis, J. Hensen, S. Adami, S. van Os & E. A. Nijland. (2008) Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women. Osteoporosis International 19:8, pages 1153-1160.
Crossref
Crossref
H. A. M. Verheul, C. J. Timmer, M. L. P. S. van Iersel, L. P. C. Delbressine & H. J. Kloosterboer. (2007) Pharmacokinetic Parameters of Tibolone and Metabolites in Plasma, Urine, Feces, and Bile from Ovariectomized Cynomolgus Monkeys after a Single Dose or Multiple Doses of Tibolone. Drug Metabolism and Disposition 35:7, pages 1112-1118.
Crossref
Crossref
E. Tsiridis, Z. Gamie, P.G. Conaghan & P.V. Giannoudis. (2007) Biological options to enhance periprosthetic bone mass. Injury 38:6, pages 704-713.
Crossref
Crossref
Peng-Hui Wang, Ming-Huei Cheng, Hsiang-Tai Chao & Kuan-Chong Chao. (2007) Effects of Tibolone on the Breast of Postmenopausal Women. Taiwanese Journal of Obstetrics and Gynecology 46:2, pages 121-126.
Crossref
Crossref
H A M Verheul, C J Timmer & H J Kloosterboer. (2007) Pharmacokinetic Parameters of Sulfated Tibolone Metabolites in Postmenopausal Women after Single and Multiple Doses of Tibolone. Clinical Pharmacology & Therapeutics 81:4, pages 573-579.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
A. Maran, K. Shogren, M. Zhang, M.J. Yaszemski, T.E. Hefferan, T.C. Spelsberg, H.J. Kloosterboer & R.T. Turner. (2006) Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone. Bone 39:3, pages 523-529.
Crossref
Crossref
Giovanni A. Tommaselli, Costantino Di Carlo, Attilio Di Spiezio Sardo, Giuseppe Bifulco, Domenico Cirillo, Maurizio Guida, Rachele Capasso & Carmine Nappi. (2006) Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause 13:4, pages 660-668.
Crossref
Crossref
Levent Yasar, Ali Süha Sönmez, Nurhan Utku, Jane Özcan, Ziya Çebi, Kadir Savan, Necdet Sut & Fehmi Yazıcıoğlu. (2006) Effect of misoprostol on bone mineral density in women with postmenopausal osteoporosis. Prostaglandins & Other Lipid Mediators 79:3-4, pages 199-205.
Crossref
Crossref
V. Daniel Castracane, Ginger R. Kraemer, Beverly W. Ogden & Robert R. Kraemer. (2006) Interrelationships of serum estradiol, estrone, and estrone sulfate, adiposity, biochemical bone markers, and leptin in post-menopausal women. Maturitas 53:2, pages 217-225.
Crossref
Crossref
Kuan-Chong Chao, Peng-Hui Wang, Ming-Shyen Yen, Ching-Ying Chang, Chin-Mu Juang, Nae-Fan Twu & Hwa-Shi Wu. (2005) New Selective Tissue Estrogenic Activity Regulator (STEAR) in Menopausal Therapy in Taiwan. Taiwanese Journal of Obstetrics and Gynecology 44:4, pages 327-331.
Crossref
Crossref
Mihail A. Boyanov & Alexander D. Shinkov. (2005) Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study. Maturitas 51:4, pages 363-369.
Crossref
Crossref
P. Kenemans & L. Speroff. (2005) Tibolone: Clinical recommendations and practical guidelines. Maturitas 51:1, pages 21-28.
Crossref
Crossref
Peter Kenemans. (2004) Tibolone: how does its mechanism of action translate into clinical effects. Maturitas 48, pages 1-3.
Crossref
Crossref
&NA;. (2003) Long-term treatment with tibolone increases mean bone mineral density (BMD) in postmenopausal women,. Inpharma Weekly &NA;:1375, pages 17.
Crossref
Crossref
H.J Kloosterboer & A.G.H Ederveen. (2002) Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (±progestogen) treatments. The Journal of Steroid Biochemistry and Molecular Biology 83:1-5, pages 157-165.
Crossref
Crossref